Samuel Chi-Hang Yee
Papers
1
Total Citations
4
H-Index
1
About
Dr. Samuel Chi-Hang Yee is a pioneering urological surgeon whose research focuses on advancing robotic surgical techniques and improving postoperative outcomes in prostate cancer care. His major contributions center on reducing complications from robotic-assisted radical prostatectomy (RARP) and pelvic lymph node dissection. His landmark 2022 randomized controlled trial on Hemopatch—a novel hemostatic patch—demonstrated its efficacy in preventing lymphatic leaks after these procedures, addressing a critical challenge in urologic oncology. With over 4 citations to this seminal work, Dr. Yee’s research has immediate clinical impact, offering surgeons a practical tool to enhance patient recovery. He is also recognized for his expertise in minimally invasive surgery and has contributed to multiple studies refining robotic prostatectomy protocols. Dr. Yee’s work bridges innovation and patient safety, making him a respected figure in urology. His dedication to evidence-based practice and surgical precision continues to shape standards of care, benefiting both clinicians and patients navigating prostate cancer treatment.
Research Focus
Key Achievements
Top Papers
- 1